The novel coronavirus appears to be causing sudden strokes in adults in their 30s and 40s who are not otherwise terribly ill, doctors say
Dr. Rick Bright had led BARDA, the Biomedical Advanced Research and Development Authority, since 2016 until Tuesday, when was reassigned to a narrower position. He also announced he will file a whistleblower complaint with the Department of Health and Human Services' inspector general.
A spokesperson for the Department of Health and Human Services confirmed Bright's move in a statement to CNN Tuesday and said he will now lead a new government project: a public-private partnership on vaccine development and treatment. "On April 17, the National Institutes of Health announced a new public-private partnership -- the Accelerating COVID-19 Therapeutic Interventions and Vaccines partnership -- to accelerate the development of COVID-19 vaccine and treatment options.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Director of key Trump administration vaccine agency suddenly departsThe director of the agency responsible for leading the charge on the production and purchase of vaccines in the Trump administration is no longer leading the agency as of Tuesday, CNN has confirmed.
Leer más »
I’m Working 14-hour Days To Develop The Coronavirus VaccineHanneke Schuitemaker is working day and night to develop a coronavirus vaccine. 'We have no time to lose,' she says.
Leer más »
'Anti-Vax' Mom Says the Coronavirus Has Made Her Rethink Her Stance on VaccinesThe global pandemic and anticipation of a vaccine is causing some who previously opposed immunization to reconsider their views.
Leer más »
What’s Going on With Texas’s Coronavirus Abortion Ban?A federal appeals court ruled Monday that Texas can once again suspend medication abortion services amid the coronavirus pandemic
Leer más »
Germany to start first clinical tests on virus vaccineThe trial will be conducted on 200 healthy people aged between 18 and 55 in the first stage and on more people, including those at higher risk from the disease, in a second stage.
Leer más »